Artcline GmbH | WebDisclosure

Basculer en Français

9820	Companies
197077	Keywords
128165	Articles
104819	Press releases

Home
Companies
Artcline GmbH

BRIEF

published on 01/20/2026 at 10:05, 17 days 22 hours ago

ARTCLINE Appoints New Chairman and Gears Up for Sepsis Therapy Launch

Biotechnology ARTCLINE Sepsis Therapy Peters Llewellyn-Davies ARTICE®
BRIEF

published on 01/20/2026 at 10:05, 17 days 22 hours ago

ARTCLINE nomme un nouveau président et se prépare au lancement de son traitement contre la septicémie

Biotechnologie ARTCLINE Peters Llewellyn-Davies ARTICE® Traitement De La Septicémie
PRESS RELEASE

published on 01/20/2026 at 10:00, 17 days 22 hours ago

ARTCLINE appoints Peter Llewellyn-Davies as Chairman of the Supervisory Board and accelerates commercialization of innovative sepsis therapy
ARTCLINE appoints Peter Llewellyn-Davies as Chairman of the Supervisory Board, accelerating commercialization of innovative sepsis therapy with ARTICE® therapy for immune dysfunction in septic shock

Commercialization ARTICE® Therapy ARTCLINE Sepsis Therapy Peter Llewellyn-Davies
BRIEF

published on 09/09/2025 at 10:05, 4 months 27 days ago

ARTCLINE Secures €5 Million for Clinical Trial Advancement

Clinical Trial Septic Shock ARTICE® Therapy ARTCLINE GmbH €5 Million Financing
BRIEF

published on 09/09/2025 at 10:05, 4 months 27 days ago

ARTCLINE obtient 5 millions d'euros pour l'avancement des essais cliniques

Essai Clinique ARTCLINE GmbH Choc Septique Thérapie ARTICE® Financement De 5 Millions D'euros
PRESS RELEASE

published on 09/09/2025 at 10:00, 4 months 27 days ago

ARTCLINE announces closing of €5 million financing
ARTCLINE GmbH successfully closes €5 million convertible loan to secure the completion and evaluation of ongoing clinical trial ReActIF-ICE for septic shock treatment. Webinar announced for 29 September 2025

Financing Webinar Clinical Trial Septic Shock ARTCLINE GmbH
BRIEF

published on 07/28/2025 at 10:05, 6 months 9 days ago

ARTCLINE Advances with 100 Patients Enrolled in Septic Shock Study

Germany Clinical Study Septic Shock Immune Support ARTICE® Therapy
BRIEF

published on 07/28/2025 at 10:05, 6 months 9 days ago

ARTCLINE progresse avec 100 patients inscrits à l'étude sur le choc septique

Allemagne Étude Clinique Soutien Immunitaire Choc Septique Thérapie ARTICE®
PRESS RELEASE

published on 07/28/2025 at 10:00, 6 months 9 days ago

ARTCLINE: rapid progress in multicenter clinical study on immune support in septic shock – 100 patients enrolled
ARTCLINE reports rapid progress in multicenter clinical study on immune support in septic shock with 100 patients already enrolled. Study aims to validate ARTICE(R) therapy benefits for critical condition treatment

Clinical Trial Septic Shock Immune Support ARTCLINE Multicenter Study
BRIEF

published on 05/22/2025 at 13:05, 8 months 15 days ago

ARTCLINE Forms Scientific Advisory Board to Enhance Sepsis Treatment

Scientific Advisory Board Septic Shock ARTICE® Therapy Immune Cell Therapy ReActIF-ICE Study

Accesswire

Published on 02/07/2026 at 01:00, 7 hours 15 minutes ago

Green Bridge Metals Can Help Secure U.S. Production of Critical Mineral Titanium
Published on 02/06/2026 at 23:10, 9 hours 5 minutes ago

Topline Capital Management, LLC Announces Disposition of Shares of NamSys Inc.
Published on 02/06/2026 at 22:01, 10 hours 14 minutes ago

Totec Resources Announces Listing of Shares on the Frankfurt Stock Exchange and Adoption of Omnibus Incentive Plan
Published on 02/06/2026 at 15:30, 16 hours 45 minutes ago

Vulcan Minerals Inc. - Drilling Program Update for the Carbonear Zinc-Lead SEDEX project in Newfoundland
Published on 02/06/2026 at 13:30, 18 hours 45 minutes ago

Redwood AI Corp. (formerly Marshall Technologies Corp.) Announces Closing of IPO and Listing of Shares on the Canadian Securities Exchange

View all ACCESSWIRE

EQS Group

Published on 02/06/2026 at 19:25, 12 hours 49 minutes ago

Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 02/06/2026 at 17:52, 14 hours 23 minutes ago

EQS-Adhoc: Avemio AG: Preparation of the filing for insolvency proceedings by Teltec AG, a subsidiary of Avemio AG, and potential effects on the going-concern assessment of Avemio AG
Published on 02/06/2026 at 17:40, 14 hours 35 minutes ago

Carvolix : Nombre d’actions composant le capital social et nombre total de droits de vote au 31.01.26.
Published on 02/06/2026 at 16:55, 15 hours 20 minutes ago

GAC MPV Serves as Official Reception Fleet for APEC China 2026, Demonstrating the Strength of Chinese Manufacturing
Published on 02/06/2026 at 15:25, 16 hours 50 minutes ago

CES 2026 Innovation Award Honoree iGarden M1 Pro Max Launches as World's First Bionic Dual-Vision Pool Cleaner

Les Echos

Published on 02/06/2026 at 18:22, 13 hours 53 minutes ago

Déclaration du nombre d’actions et droits de vote au 31 janvier 2026
Published on 02/06/2026 at 18:22, 13 hours 53 minutes ago

Disclosure of Share Capital and Voting Rights as of January 31, 2026
Published on 02/06/2026 at 16:01, 16 hours 14 minutes ago

Notice of exercise of early redemption option of the subordinated note ISIN : FR0010093328
Published on 02/06/2026 at 16:01, 16 hours 14 minutes ago

Exercice de l’option de remboursement de l'instrument subordonné FR0010093328
Published on 02/06/2026 at 07:54, 1 day ago

ENGIE - Déclaration du nombre total d'actions et de droits de vote au 31 janvier 2026

View all LES ECHOS COMFI WIRE